Bionano Genomics, Inc. (BNGO) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bionano Genomics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.156 Good day, and welcome to the BioNano first quarter 2026 earnings conference call. 00:00:05.156 -- 00:00:09.320 Today's conference is being recorded. At this time, I would like to turn the conference 00:00:09.320 -- 00:00:11.462 over to Webb Campbell from Gilmartin Group. 00:00:11.462 -- 00:00:13.822 Please go ahead. 00:00:14.385 -- 00:00:16.807 Thank you, Liz, and good afternoon, everyone. 00:00:16.807 -- 00:00:21.792 Welcome to the BioNano first quarter 2026 financial results conference call. 00:00:21.792 -- 00:00:27.017 On the call today is Dr. Al Luterer, Chairman and Interim CEO of BioNano, and Mark 00:00:27.017 -- 00:00:31.863 Adamchak, Bionano's Vice President of Accounting and Principal Accounting Officer. 00:00:31.863 -- 00:00:36.889 After market closed today, Bionano issued a press release announcing its financial results 00:00:36.889 -- 00:00:39.613 for the first quarter of 2026. 00:00:39.613 -- 00:00:45.140 A copy of the release can be found on the investor relations page of the company's website. 00:00:45.140 -- 00:00:50.526 Certain statements made during this conference call may be forward-looking statements. 00:00:50.526 -- 00:00:55.773 Actual results may differ materially from such statements due to several factors 00:00:55.773 -- 00:01:01.125 and risk. some of which are identified in BioNano's press release and BioNano's reports 00:01:01.125 -- 00:01:06.452 filed with the SEC. These forward-looking statements are based on information 00:01:06.452 -- 00:01:10.698 available to BioNano today, May 13, 2026, 00:01:10.698 -- 00:01:16.326 and the company assumes no obligation to update statements as circumstances change. 00:01:16.326 -- 00:01:21.532 During our call, we may refer to certain adjusted financial measures, whic...